Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hepatocholangiocarcinoma]

Z Gonciarz1, D Obrebska, P Besser

  • 1VII Katedry i Kliniki Chorób Wewnetrznych Slaskiej Ak. Med. w Katowicach.

Wiadomosci Lekarskie (Warsaw, Poland : 1960)
|October 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Disseminated varicella zoster virus and herpes simplex virus co-infection in a lung-transplant recipient.

Annales de dermatologie et de venereologie·2021
Same author

Real life results of direct acting antiviral therapy for HCV infection in HIV-HCV-coinfected patients: Epi-Ter2 study.

AIDS care·2019
Same author

Treatment of HCV infection in Poland at the beginning of the interferon-free era-the EpiTer-2 study.

Journal of viral hepatitis·2018
Same author

Reduction of CD45RA Isoform Expression and Decrease in CD4 and CD8 Receptor Density in Lymphocytes of Patients with Primary Biliary Cirrhosis.

Scandinavian journal of gastroenterology·2017
Same author

Randomised clinical trial: alisporivir combined with peginterferon and ribavirin in treatment-naïve patients with chronic HCV genotype 1 infection (ESSENTIAL II).

Alimentary pharmacology & therapeutics·2015
Same author

Elevated sputum BPIFB1 levels in smokers with chronic obstructive pulmonary disease: a longitudinal study.

American journal of physiology. Lung cellular and molecular physiology·2015

This case report details an extremely rare mixed hepatocholangiocellular carcinoma in a 48-year-old man. Diagnosis was challenging due to combined hepatocellular and bile duct cancer features.

Area of Science:

  • Hepatobiliary pathology
  • Oncology
  • Diagnostic imaging

Background:

  • Hepatocellular carcinoma (HCC) and cholangiocellular carcinoma (CCC) are primary liver cancers with distinct origins and characteristics.
  • Mixed hepatocholangiocellular carcinoma (HCCC) represents a rare entity combining features of both HCC and CCC.
  • Accurate diagnosis is crucial for appropriate treatment and prognosis.

Observation:

  • A 48-year-old male presented with a right hepatic lobe tumor detected via imaging.
  • Elevated serum alpha-fetoprotein (AFP) and des-gamma-carboxyprothrombin (DCP) suggested HCC.
  • Liver biopsy revealed bile duct origin (CCC), contrasting initial serological markers.

Findings:

  • Histological examination of surgical and autopsy specimens confirmed distinct foci of both HCC and CCC.

Related Experiment Videos

  • The tumor exhibited a mixed morphology, characteristic of hepatocholangiocellular carcinoma.
  • The case highlights diagnostic discrepancies between serological markers and histological findings in mixed liver tumors.

    • Implications:

    • This case underscores the diagnostic challenges posed by rare mixed liver cancers.
    • It emphasizes the importance of integrating imaging, serological markers, and histology for accurate HCCC diagnosis.
    • Understanding HCCC's rarity and diagnostic complexity is vital for clinical management and future research.